Does PALBOCICLIB Cause Dyspnoea exertional? 341 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 341 reports of Dyspnoea exertional have been filed in association with PALBOCICLIB (Ibrance). This represents 0.4% of all adverse event reports for PALBOCICLIB.
341
Reports of Dyspnoea exertional with PALBOCICLIB
0.4%
of all PALBOCICLIB reports
16
Deaths
107
Hospitalizations
How Dangerous Is Dyspnoea exertional From PALBOCICLIB?
Of the 341 reports, 16 (4.7%) resulted in death, 107 (31.4%) required hospitalization, and 4 (1.2%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 341 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which PALBOCICLIB Alternatives Have Lower Dyspnoea exertional Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID